HKEX Biotech Summit 2023

Mr. Li was born in Beijing and grew up in Gansu. Before leaving China for further study, Mr. Li was an offshore oil worker in the North China Sea and then an editor-reporter for China Daily. After completing his Juris Doctor (JD) degree in the US, Mr. Li practiced law in New York with Davis Polk & Wardwell and Brown & Wood. Before joining HKEX, he was Chairman of JP Morgan China, prior to which he was President of Merrill Lynch China.

Mr. Li obtained a BA degree in English literature from Xiamen University in 1984, an MA degree in journalism from the University of Alabama in 1988, and a JD degree from Columbia University School of Law in 1991.

Mr. Li was born in Beijing and grew up in Gansu. Before leaving China for further study, Mr. Li was an offshore oil worker in the North China Sea and then an editor-reporter for China Daily. After completing his Juris Doctor (JD) degree in the US, Mr. Li practiced law in New York with Davis Polk & Wardwell and Brown & Wood. Before joining HKEX, he was Chairman of JP Morgan China, prior to which he was President of Merrill Lynch China.

Mr. Li obtained a BA degree in English literature from Xiamen University in 1984, an MA degree in journalism from the University of Alabama in 1988, and a JD degree from Columbia University School of Law in 1991.

Mr. Zhang is deeply involved in educational endeavors. He earned his M.B.A and M.A. in International Relations from Yale University and is a member of the Yale Board of Trustees. He also serves as Chair of the Yale Asia Development Council. Before attending Yale, he earned his B.A. in Economics from the Renmin University of China, where he is Vice Chairman of the Board of Trustees. A recent gift from Mr. Zhang helped establish the Hillhouse Academy, which works with students from universities around China. Mr. Zhang is a founding Trustee of Westlake University, where he is also a founding donor of the Endowment and the Chairman of the Development Council. 

Mr. Zhang is deeply involved in educational endeavors. He earned his M.B.A and M.A. in International Relations from Yale University and is a member of the Yale Board of Trustees. He also serves as Chair of the Yale Asia Development Council. Before attending Yale, he earned his B.A. in Economics from the Renmin University of China, where he is Vice Chairman of the Board of Trustees. A recent gift from Mr. Zhang helped establish the Hillhouse Academy, which works with students from universities around China. Mr. Zhang is a founding Trustee of Westlake University, where he is also a founding donor of the Endowment and the Chairman of the Development Council. 

In 2009, Dr. Yu returned back to China and established CanSino Biologics Inc. (CanSinoBIO), an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. With his 30 years of experience in the development of biological products and enterprise management and operation, CanSinoBIO has currently built the pipelines of 16 vaccine candidates for 13 infectious diseases, including the world's initial vaccine for Ebola virus disease as well as the potential vaccine candidate against COVID-19. 

In 2009, Dr. Yu returned back to China and established CanSino Biologics Inc. (CanSinoBIO), an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. With his 30 years of experience in the development of biological products and enterprise management and operation, CanSinoBIO has currently built the pipelines of 16 vaccine candidates for 13 infectious diseases, including the world's initial vaccine for Ebola virus disease as well as the potential vaccine candidate against COVID-19. 

Committed to the success of Hong Kong’s future, Albert and his team are responsible for providing world-class services at the Park, to achieve their objective of helping technology companies and talents to realise their commercial potential. These services include technology incubation programmes, tools and research labs for application and product development, early-stage investments, mentoring and business consulting, and connecting Park companies with local industry and trade associations. 

Outside of work, Albert actively contributes to the community. He is a member of The Court of The University of Hong Kong and a board member the Hong Kong Sports Institute. An avid runner, Albert regularly takes part in marathons around the world.

Committed to the success of Hong Kong’s future, Albert and his team are responsible for providing world-class services at the Park, to achieve their objective of helping technology companies and talents to realise their commercial potential. These services include technology incubation programmes, tools and research labs for application and product development, early-stage investments, mentoring and business consulting, and connecting Park companies with local industry and trade associations. 

Outside of work, Albert actively contributes to the community. He is a member of The Court of The University of Hong Kong and a board member the Hong Kong Sports Institute. An avid runner, Albert regularly takes part in marathons around the world.

Prior to joining Chi-Med, Mr. Hogg spent ten years with P&G, starting in the United States in Finance and then Brand Management in the Laundry and Cleaning Products Division. He then moved to China to manage P&G’s detergent business, followed by a move to Brussels to run P&G’s global bleach business.

Prior to joining Chi-Med, Mr. Hogg spent ten years with P&G, starting in the United States in Finance and then Brand Management in the Laundry and Cleaning Products Division. He then moved to China to manage P&G’s detergent business, followed by a move to Brussels to run P&G’s global bleach business.

Mr. Gwénaël Meneux is General Manager of Hong Kong and Macau at AstraZeneca since September 2018. He is a member of AstraZeneca China Senior Management Team since 2016

He was elected at HKAPI Board of Directors in July 2019 and he’s also an active member of the Healthcare Committee of the British Chamber of Commerce

Gwénaël joined AstraZeneca France in February 2009 and acted as Sales Force Excellence Director and Customer Excellence Director successively. He joined AstraZeneca China in September 2016 as Vice President for Commercial Strategy & Excellence

Gwénaël began his career in 1998 at L’Oréal (FMCG division) where he held several sales and marketing positions. Later he joined the Boston Consulting Group as Senior Consultant

Gwénaël holds a MSc in Management from ESSEC Business School (France)

Mr. Gwénaël Meneux is General Manager of Hong Kong and Macau at AstraZeneca since September 2018. He is a member of AstraZeneca China Senior Management Team since 2016

He was elected at HKAPI Board of Directors in July 2019 and he’s also an active member of the Healthcare Committee of the British Chamber of Commerce

Gwénaël joined AstraZeneca France in February 2009 and acted as Sales Force Excellence Director and Customer Excellence Director successively. He joined AstraZeneca China in September 2016 as Vice President for Commercial Strategy & Excellence

Gwénaël began his career in 1998 at L’Oréal (FMCG division) where he held several sales and marketing positions. Later he joined the Boston Consulting Group as Senior Consultant

Gwénaël holds a MSc in Management from ESSEC Business School (France)